Literature DB >> 19346727

[Acute pancreatitis associated with the administration of ceftriaxone in an adult patient].

Yumihiko Sasaki1, Sachiko Aoki, Kota Aoki, Koichi Achiwa, Tsuyoki Yama, Minoru Kubota, Daisuke Ishikawa, Tetsuya Mizutani, Shin Kunii, Kazumasa Watanabe, Akihiko Okumura.   

Abstract

We report a case of a 35-year-old patient with acute pancreatitis after administration of ceftriaxone. She was given ceftriaxone (2g/day) for 9 days because of diverticulitis of the colon. She was admitted to our hospital again because of epigastralgia 12 days after the first administration of ceftriaxone. Laboratory examination showed markedly elevated serum amylase, and CT scan demonstrated findings consistent with acute pancreatitis, in addition to sludge in the common bile duct and gall bladder, which was not identified before the administration of ceftriaxone. We should be aware of the fact that administration of ceftriaxone sometimes results in the formation of biliary sludge and can cause severe adverse events such as cholecystitis and pancreatitis, not only in children, but also in adult patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346727

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  3 in total

1.  Ceftriaxone-Induced Pancreatitis.

Authors:  Muneerah M Albugami; Mohamed Ahmed; Abdulelah Bin Shihah
Journal:  Can J Hosp Pharm       Date:  2021-07-01

2.  Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction.

Authors:  Aya Imafuku; Naoki Sawa; Akinari Sekine; Masahiro Kawada; Rikako Hiramatsu; Masayuki Yamanouchi; Eiko Hasegawa; Noriko Hayami; Jyunichi Hoshino; Yoshifumi Ubara; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2017-10-12       Impact factor: 2.801

3.  Ceftriaxone-associated pancreatitis captured on serial computed tomography scans.

Authors:  Nozomu Nakagawa; Nobuaki Ochi; Hiromichi Yamane; Yoshihiro Honda; Yasunari Nagasaki; Noriyo Urata; Hidekazu Nakanishi; Hirofumi Kawamoto; Nagio Takigawa
Journal:  Radiol Case Rep       Date:  2017-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.